Enzyme expression profiles suggest the novel tumor-activated fluoropyrimidine carbamate capecitabine (Xeloda) might be effective against papillary thyroid cancers of children and young adults

Aneeta Patel, Thomas Pluim, Amy Helms, Andrew Bauer, R. Michael Tuttle, Gary L. Francis

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint Dive into the research topics of 'Enzyme expression profiles suggest the novel tumor-activated fluoropyrimidine carbamate capecitabine (Xeloda) might be effective against papillary thyroid cancers of children and young adults'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds